Cutaneous vasculitis associated with tuberculosis and its treatment.
Two patients with pulmonary tuberculosis developed cutaneous vasculitis after antituberculosis treatment and a patient with tuberculous lymphadenitis developed vasculitis at presentation before drug therapy. The cutaneous vasculitis probably represented immunological reactions to tubercle bacilli and/or rifampicin with antibodies and immune complex formation.
Chan
C H
CH
Department of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin.
Chong
Y W
YW
Sun
A J
AJ
Hoheisel
G B
GB
D000328:Adult; D006801:Humans; D011695:IgA Vasculitis / Q000209:etiology* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects*; D014388:Tuberculosis, Lymph Node / Q000150:complications* / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy
D012293:Rifampin